Physician profile
Carrie E Black
NPI 1568661288
$2,333.19
in general payments reported to CMS, 2019-2025
13 companies · $965 in 2025
The $965 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $244 · 2021: $128 · 2022: $14.56 · 2023: $113 · 2024: $112 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $652 · Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $651.60 |
| Food and Beverage | $537.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $651.60 | 2025 | Durasorb Monofilament Mesh |
| Mentor Worldwide LLC | $267.49 | 2019-2021 | |
| Axogen | $259.05 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Allergan, INC. | $247.82 | 2019 | |
| Sientra, INC. | $239.76 | 2020-2021 | |
| Abbvie INC. | $225.89 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Orthofix Medical, INC. | $116.55 | 2019 | |
| Smith+Nephew, INC. | $114.91 | 2019-2023 | Renasys Go V2 Home |
| Alafair Biosciences, INC. | $82.49 | 2019 | |
| Stryker Corporation | $75.48 | 2020 | |
| Rti Surgical, INC | $20.27 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $17.32 | 2025 | |
| Merz North America, INC. | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.